Tested Applications
| Positive WB detected in | human skeletal muscle tissue, HeLa cells, human brain tissue |
| Positive IHC detected in | human skeletal muscle tissue, human heart tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:300-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
14702-1-AP targets MAP4K3 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag6372 Product name: Recombinant human MAP4K3 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 537-873 aa of BC071579 Sequence: KIHCASSWINPDTRDQYLIFGAEEGIYTLNLNELHETSMEQLFPRRCTWLYVMNNCLLSISGKASQLYSHNLPGLFDYARQMQKLPVAIPAHKLPDRILPRKFSVSAKIPETKWCQKCCVVRNPYTGHKYLCGALQTSIVLLEWVEPMQKFMLIKHIDFPIPCPLRMFEMLVVPEQEYPLVCVGVSRGRDFNQVVRFETVNPNSTSSWFTESDTPQTNVTHVTQLERDTILVCLDCCIKIVNLQGRLKSSRKLSSELTFDFQIESIVCLQDSVLAFWKHGMQGRSFRSNEVTQEISDSTRIFRLLGSDRVVVLESRPTDNPTANSNLYILAGHENSY Predict reactive species |
| Full Name | mitogen-activated protein kinase kinase kinase kinase 3 |
| Calculated Molecular Weight | 101 kDa |
| Observed Molecular Weight | 100 kDa |
| GenBank Accession Number | BC071579 |
| Gene Symbol | MAP4K3 |
| Gene ID (NCBI) | 8491 |
| RRID | AB_10858917 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8IVH8 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MAP4K3(Mitogen-activated protein kinase kinase kinase kinase 3) has kinase activity and that it activates JNK but not MAPK1, MAPK3 or MAPK14 through the activation of MAP3K1 and MAP2K4. Endogenous MAP4K3 kinase activity could be stimulated by exposure to ultraviolet radiation or to tumor necrosis factor.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for MAP4K3 antibody 14702-1-AP | Download protocol |
| WB protocol for MAP4K3 antibody 14702-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The MAP4K3 Polyclonal antibody (Cat# 14702-1-AP) has 1 citation. It was used in a study published in Bioengineered (2022), investigating how MAP4K3 promotes diabetic nephropathy progression via apoptosis induction, inhibited by Astragaloside IV through H3K4 monomethylation. The research field encompasses diabetic nephropathy, apoptosis, and MAPK signaling pathway regulation, with the antibody applied in Western blot (WB) for mouse and rat samples.
| Species | Application | Title |
|---|---|---|
Bioengineered Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by Astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis.
|













